|
|
|
|
Archives
|
Entry
|
Author
|
Date
|
Location
|
|
Legend 3D Lays Off 15 Percent, Avalon Ventures Holds 6.1 Percent of Zynga, SweetLabs Launches App Platform for PCs, & More San Diego BizTech News
|
Bruce V. Bigelow |
07/05/11 |
San Diego
|
|
Genzyme Borrows $1B for Stock Buyback
|
Ryan McBride |
06/15/10 |
Boston
|
|
Icahn Gets One More Seat on Biogen Board
|
Ryan McBride |
03/22/10 |
Boston
|
|
Icahn Boosts Genzyme Stake
|
Ryan McBride |
02/16/10 |
Boston
|
|
Carl Icahn Nominates Three More Candidates for Biogen Board Seats
|
Ryan McBride |
01/28/10 |
Boston
|
|
VentiRx Pharmaceuticals Raises More Funds, Genzyme Declares a Truce, Adventrx Charts Comeback, & More San Diego Life Sciences News
|
Denise Gellene |
01/14/10 |
San Diego
|
|
Scandal, Swine Flu, Shareholder Disputes, and More: 2009 Was Quite a Year for San Diego’s Life Sciences Industry
|
Denise Gellene |
12/22/09 |
San Diego
|
|
Eastbourne Dumps Amylin Shares, Illumina Inks Licensing Deal, Avanir Releases Pseudobulbar Affect Data, & More San Diego Life Sciences News
|
Denise Gellene |
10/15/09 |
San Diego
|
|
Domain Raises a $500M VC Fund, Dissident Prods Amylin Again, Avanir Passes Pivotal Test, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
08/13/09 |
San Diego
|
|
In Aftermath of Proxy Fight Amylin Pharmaceuticals Investor Expresses Concern Over Empty Board Chair Seat
|
Bruce V. Bigelow |
08/07/09 |
San Diego
|
|
Amylin Founder Ted Greene, In Exclusive Interview, Upbeat About Outcome of Proxy Battle
|
Bruce V. Bigelow |
06/02/09 |
San Diego
|
|
Amylin Pharmaceuticals Gets New Directors (But Who Are They?), Ophthonix and Vical Raise Capital, Metabasis Cuts Back—Again, & More San Diego Life Sciences News
|
Bruce V. Bigelow |
05/28/09 |
San Diego
|
|
Amylin’s Dissident Shareholders Gain Influence on Board
|
Bruce V. Bigelow |
05/27/09 |
San Diego
|
|
Amylin Shareholders Vote Today in Battle to Influence Board
|
Bruce V. Bigelow |
05/27/09 |
San Diego
|
|
Shareholder Showdown at Amylin Headquarters
|
Juha-Pekka Tikka |
05/26/09 |
San Diego
|
|
Amylin Co-Founder Ted Greene Explains His Switch in Proxy Battle
|
Bruce V. Bigelow |
05/18/09 |
San Diego
|
|
Amylin Urges Shareholders to Vote Blue
|
Juha-Pekka Tikka |
05/11/09 |
San Diego
|
|
Vical Developing Vaccine for Swine Flu, Acadia’s Stock Almost Doubles on Biovail Deal, Qualcomm Launches Business Plan Contest, & Other San Diego BizTech News
|
Bruce V. Bigelow |
05/11/09 |
San Diego
|
|
Diabetes Drug Application May Be New Factor in Amylin Proxy Battle
|
Juha-Pekka Tikka |
05/05/09 |
San Diego
|
|
Amylin Cuts 200 Sales Reps, Looks for $45M in Savings Next Year
|
Bruce V. Bigelow |
05/04/09 |
San Diego
|
|
Amylin Allows Talks Between Carl Icahn and Eastbourne
|
Juha-Pekka Tikka |
04/30/09 |
San Diego
|
|
Lilly CEO Has No Plans to Buy Amylin
|
Bruce V. Bigelow |
04/28/09 |
San Diego
|
|
No Resolution in Amylin’s Talks With Dissident Investors Carl Icahn and Eastbourne Capital, Anadys Sees Promise in Treatment for Hepatitis C, Chumby Makes Moves into Europe, & Other San Diego BizTech News
|
Juha-Pekka Tikka |
04/27/09 |
San Diego
|
|
Icahn Denounces Amylin’s Chairman
|
Bruce V. Bigelow |
04/15/09 |
San Diego
|
|
Amylin Braces for Proxy Battle Amid Flurry of Filings
|
Bruce V. Bigelow |
04/09/09 |
San Diego
|
|
Page 1 of
1 |
|
Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.
© 2007-2012, Xconomy, Inc.
Xconomy is a registered service mark of Xconomy, Inc.
All rights reserved.
Site produced by Andrew Koyfman with design from Rob Hunter.